Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma

Condition:   Asthma
Interventions:   Drug: QGE031;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting – verified January 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.